Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment

NCT03289208 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tanabe Pharma Corporation